A302550 logo

Remed Co.,Ltd. Stock Price

KOSDAQ:A302550 Community·₩99.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A302550 Share Price Performance

₩0
-3895.00 (-100.00%)
₩0
-3895.00 (-100.00%)
Price ₩0

A302550 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with proven track record.

2 Risks
2 Rewards

Remed Co.,Ltd. Key Details

₩24.5b

Revenue

₩10.4b

Cost of Revenue

₩14.1b

Gross Profit

₩7.6b

Other Expenses

₩6.5b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
208.22
57.69%
26.46%
9.3%
View Full Analysis

About A302550

Founded
2003
Employees
89
CEO
Geun-Yong Lee
WebsiteView website
remed.kr

Remed Co.,Ltd. engages in the manufactures and supplies of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as tinnitus, insomnia, dementia, stress, anxiety, etc. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides extracorporeal shock wave therapy; and technology to activate the sensory function of prostate and strengthen the pelvic floor muscle by stimulating them with electromagnetic pulse. The company was formerly known as CR Technology Co., Ltd. and changed its name to Remed Co., Ltd. in 2013. Remed Co., Ltd. was founded in 2003 and is headquartered in Daejeon, South Korea.

Recent A302550 News & Updates

RemedLtd (KOSDAQ:302550) Seems To Use Debt Quite Sensibly

Sep 18
RemedLtd (KOSDAQ:302550) Seems To Use Debt Quite Sensibly

Recent updates

No updates